Janus Capital Management LLC decreased its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 30.2% during the first quarter, Holdings Channel reports. The firm owned 50,128 shares of the company’s stock after selling 21,655 shares during the period. Janus Capital Management LLC’s holdings in Express Scripts Holding were worth $3,304,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Hancock Holding Co. raised its position in Express Scripts Holding by 9.9% in the first quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock valued at $12,094,000 after buying an additional 16,536 shares during the period. Van ECK Associates Corp raised its position in Express Scripts Holding by 28.8% in the first quarter. Van ECK Associates Corp now owns 373,636 shares of the company’s stock valued at $24,626,000 after buying an additional 83,568 shares during the period. Twin Capital Management Inc. raised its position in Express Scripts Holding by 0.8% in the first quarter. Twin Capital Management Inc. now owns 46,560 shares of the company’s stock valued at $3,069,000 after buying an additional 360 shares during the period. ACR Alpine Capital Research LLC raised its position in Express Scripts Holding by 6.3% in the first quarter. ACR Alpine Capital Research LLC now owns 1,463,799 shares of the company’s stock valued at $96,479,000 after buying an additional 87,292 shares during the period. Finally, Wilkins Investment Counsel Inc. raised its position in Express Scripts Holding by 6.9% in the first quarter. Wilkins Investment Counsel Inc. now owns 118,336 shares of the company’s stock valued at $7,800,000 after buying an additional 7,630 shares during the period. 90.20% of the stock is owned by hedge funds and other institutional investors.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded up 0.86% during mid-day trading on Friday, reaching $60.82. 2,898,864 shares of the company traded hands. Express Scripts Holding Company has a 52-week low of $57.80 and a 52-week high of $77.61. The company’s 50 day moving average is $62.73 and its 200 day moving average is $64.48. The stock has a market capitalization of $35.13 billion, a price-to-earnings ratio of 10.56 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company’s revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.57 EPS. On average, equities analysts forecast that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.watchlistnews.com/janus-capital-management-llc-sells-21655-shares-of-express-scripts-holding-company-nasdaqesrx/1479371.html.

Several equities analysts have recently weighed in on ESRX shares. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Mizuho cut their target price on shares of Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating for the company in a report on Tuesday, April 25th. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They issued a “hold” rating on the stock. Cowen and Company reissued an “outperform” rating and issued a $83.00 price target on shares of Express Scripts Holding in a research note on Friday, June 9th. Finally, Evercore ISI dropped their price target on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 26th. Four equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $71.17.

In related news, VP Phyllis S. Anderson sold 1,100 shares of the firm’s stock in a transaction dated Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the sale, the vice president now directly owns 11,108 shares in the company, valued at approximately $667,368.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.68% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.